Skip to main content
. 2023 May 24;44(10):2004–2018. doi: 10.1038/s41401-023-01101-x

Fig. 6. The cardioprotective effect of FGF10 is mediated through FGFR2.

Fig. 6

a, b Western blot analyses of FGFR2 and phosphorylated FGFR2 expression in mouse heart tissues of the indicated groups at 12 h post doxorubicin injection. c Statistical analysis of the Western blotting data presented in a and b. d Immunoblot detection of FGFR2 and phosphorylated FGFR2 in HL-1 cells of indicated groups at 12 h post doxorubicin administration. e Immunoblot detection of total and phospho FGFR2 in FGFR2 stable expression HL-1 stable cells (Vector CONTROL, C383R and Y657/658F, respectively) with or without FGF10. f Statistical analysis of the immunoblot data presented in d and e. g Representative images of SOD, 53BP1, and TUNEL staining in DTG and CTRL mice. h Statistical analysis of the images presented in g. i Western blot analysis of C-CAS3 and SOD with GAPDH as an internal control in HL-1 cells. j Statistical analysis of the data presented in i. (DTG), Rosa26rtTA/rtTA; tet(O) sFgfr2b/+, and the control mice (CTRL). ns, non-significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Abbreviations: DTG, Rosa26rtTA/rtTA; tet(O) sFgfr2b/+; CTRL, the control mice. Scaler bar: 100 μm.